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Background
Survivors of critical illness demonstrate skeletal muscle
wasting with associated functional impairment.
Methods
Objective: The objective was to perform a comprehen-
sive prospective characterization of skeletal muscle wast-
ing, defining the pathogenic roles of altered protein
synthesis and breakdown.
Design: Prospective observational study.
Setting: Patients were recruited from a university and
community hospital in England.
Subjects: The study involved 63 critically ill patients
>18 years old who were anticipated to be intubated
>48 hours and to spend >7 days in the ICU and to sur-
vive their ICU stay. Subjects were enrolled within
24 hours of admission.
Outcomes: Muscle loss was determined through serial
ultrasound measurement of the rectus femoris cross-
sectional area (CSA) on days 1, 3, 7, and 10. In a subset
of patients, the fiber CSA area was quantified along with
the ratio of protein to DNA on days 1 and 7. Histo-
pathological analysis was performed. In addition, muscle* Correspondence: yendes@upmc.edu
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signaling pathways were characterized.
Results
There were significant reductions in the rectus femoris
CSA observed at day 10 (−17.7%; 95% confidence inter-
val (CI), −25.9 to 8.1%; P <0.001). In the 28 patients
assessed by all three measurement methods on days 1
and 7, the rectus femoris CSA decreased by 10.3% (95%
CI, 6.1 to 14.5%), the fiber CSA by 17.5% (95% CI, 5.8 to
29.3%), and the ratio of protein to DNA by 29.5% (95%
CI, 13.4 to 45.6%). Decrease in the rectus femoris CSA
was greater in patients who experienced multiorgan fail-
ure by day 7 (−15.7%; 95% CI, −27.7 to 11.4%) compared
with single organ failure (−3.0%; 95% CI, −5.3 to 2.1%;
P <0.001), even by day 3 (−8.7%; 95% CI, −59.3 to 50.6%
versus −1.8%; 95% CI, −12.3 to 10.5%, respectively;
P =0.03). Myofiber necrosis occurred in 20 of 37 patients
(54.1%). Protein synthesis measured by the muscle pro-
tein fractional synthetic rate was depressed in patients
on day 1 (0.035%/hour; 95% CI, 0.023 to 0.047%/hour)
compared with rates observed in fasted healthy controls
(0.039%/hour; 95% CI, 0.029 to 0.048%/hour; P =0.57)
and increased by day 7 (0.076%; 95% CI, 0.032
to 0.120%/hour; P =0.03) to rates associated with fed
controls (0.065%/hour; 95% CI, 0.049 to 0.080%/hour;
P =0.30), independent of nutritional load. Leg protein
breakdown remained elevated throughout the study (8.5;
95% CI, 4.7 to 12.3 μmol phenylalanine/minute/ideal
body weight × 100 to 10.6; 95% CI, 6.8 to 14.4 μmol
phenylalanine/minute/ideal body weight × 100; P =0.40).
The pattern of intracellular signaling supported in-
creased breakdown (n =9, r = −0.83, P =0.005) and de-
creased synthesis (n =9, r = −0.69, P =0.04).
Conclusions
Among these critically ill patients, muscle wasting oc-
curred early and rapidly during the first week of critical
illness and was more severe among those withCentral Ltd. This is an Open Access article distributed under the terms of the
reativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution,
original work is properly credited. The Creative Commons Public Domain
/publicdomain/zero/1.0/) applies to the data made available in this article, unless
Lodeserto and Yende Critical Care 2014, 18:617 Page 2 of 3
http://ccforum.com/content/18/6/617multiorgan failure compared with single organ failure.
These findings may provide insights into skeletal muscle
wasting and critical illness.
Commentary
Critical illness myopathy (CIM) and critical illness poly-
neuropathy (CIP) are common problems affecting nearly
50% of critically ill patients and are major contributors
to increased morbidity and mortality [1-3]. There is sig-
nificant overlap between the clinical presentation of CIP
and CIM, including symmetrical weakness, decreased or
even loss of deep tendon reflexes, and weaning difficulties.
Both CIP and CIM often lead to a prolonged ICU and
hospital course as well as a need for rehabilitation [2-4].
Many studies have grouped these processes together due
to difficulties in clinically differentiating them, and they
are commonly referred to as ICU-acquired weakness or
critical illness neuromyopathy [2-5].
Although the clinical symptoms of CIP and CIM may
share common features, and frequently coexist, several
studies have explored mechanisms underlying each condi-
tion. CIM or skeletal muscle wasting is a complex prob-
lem mediated by multiple factors. Many mechanisms for
CIM have been proposed, including elevated proteolysis,
decreased protein synthesis, and sodium channel inactiva-
tion leading to membrane inexcitability and nitric oxide
production [3]. Proposed risk factors leading to muscle
wasting are numerous, including immobilization [2,3],
systemic inflammation [2,3,5], hyperglycemia [2,3], and
nutritional factors [2,3].
Puthucheary and colleagues conducted the present
prospective observational study to understand the mech-
anisms underlying skeletal muscle wasting. They were
specifically interested in examining the relationship be-
tween protein homeostasis (anabolism versus catabol-
ism) and skeletal muscle wasting.
The investigators studied 63 critically ill patients and
performed serial ultrasound-guided assessment of the
cross-sectional area of rectus femoris muscle to study
muscle changes. They also performed muscle biopsies,
looking specifically at decreases in myofiber area and
ratio of protein to DNA (loss of muscle mass) to exam-
ine histopathological changes. Finally, they tried to ap-
proach the problem from a biochemical/molecular level
by measuring the rates of muscle protein synthesis and
breakdown after infusion of amino acid and incorpor-
ation into the muscle tissue. The study was rigorous and
required serial measurements at many levels to help
uncover a complex multifactorial process. The major
conclusions are that muscle wasting occurred early in
critical illness, was more profound in multiorgan failure,
and is a consequence of impaired protein synthesis lead-
ing to a net catabolic state.The authors’ two major conclusions have important
clinical implications, especially for the timing of muscle
wasting and its development despite enteral nutrition.
The first major conclusion was that muscle wasting
occurred early (first 10 days) and was more profound in
multiorgan failure. These findings support previous re-
ports that CIM and CIP occur early in critical illness [5].
Unfortunately, few interventions are available to prevent
or treat CIM; for instance, avoidance of risk factors, such
as hyperglycemia [6], and early mobilization and re-
habilitation [7].
Puthucheary and colleagues’ second major conclusion
is that the net catabolic state, resulting in skeletal muscle
wasting, is a consequence of decreased muscle protein
synthesis rather than increased protein breakdown. The
authors demonstrated this by showing that protein syn-
thesis was similar on day 1 of critical illness compared
with fasted healthy subjects, and increased by day 7 and
was comparable with well-fed healthy subjects. On day 1
the muscle protein synthetic rate was decreased compared
with muscle protein breakdown, resulting in an overall net
catabolic state – and the same relationship persisted on
day 7. This finding is supported by earlier studies suggest-
ing that muscle catabolism is a result of impaired synthe-
sis rather than elevated breakdown [8].
Of importance, the majority of these patients (82%)
who demonstrated impaired protein synthetic rates were
being fed continuously by the enteral route. The authors
noted an association between increased protein delivery
and muscle wasting. While this association may seem
counterintuitive, prior physiologic studies demonstrated
that the use of continuous intravenous amino acid infu-
sions led to an initial increase in protein synthesis followed
by inhibition of protein synthesis over time [9,10]. Al-
though continuous enteral feeding is the mainstay of crit-
ical care practice, the findings of this study and others
raise questions about the optimal amount of protein deliv-
ered and the feeding regimens used (continuous versus
intermittent).
Recommendation
This study confirms that skeletal muscle weakness oc-
curs early during critical illness. Skeletal muscle wasting
is largely due to depressed protein synthesis. Various
modifiable and nonmodifiable factors influence skeletal
muscle wasting. Future studies should examine the role
of various interventions, including different feeding regi-
mens, to prevent muscle wasting in critically ill patients.
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